We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nanoparticles Enhance Scorpion Venom Anticancer Properties

By LabMedica International staff writers
Posted on 27 Apr 2009
Researchers have found that linking a candidate chemotherapeutic drug to a nanoparticle delivery system more than doubled the effectiveness of the drug on cultures of brain tumor cells.

The drug of interest was chlorotoxin, a small peptide isolated form scorpion venom. Chlorotoxin affects brain cells through its interaction with a protein called MMP-2, which allows the penetration of normal and tumor cells through tissue barriers. Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMPs are secreted as inactive proproteins that are activated when cleaved by extracellular proteinases. Chlorotoxin exerts a dual effect on MMP-2: it inhibits the enzymatic activity of MMP-2 and causes a reduction in the surface expression of MMP-2.

Investigators at the University of Washington (Seattle, USA) attached chlorotoxin to nanoparticles comprising an iron oxide nanoparticle core conjugated with an amine-functionalized poly(ethylene glycol) silane. Nanoparticle bound and unbound chlorotoxin were administered to cultures of mouse brain cancer cells.

Results published in the January 19, 2009, issue of the journal Small revealed that the nanoparticles exhibited substantially enhanced cellular uptake and an invasion inhibition rate of nearly 98% as compared to the 45% invasion inhibition rate of the unbound chlorotoxin. Data from flow cytometry analysis, transmission electron microscopy, and fluorescent imaging showed that the chlorotoxin-enabled nanoparticles deactivated the cells' membrane-bound matrix MMP-2.
"People talk about the treatment being more effective with nanoparticles but they do not know how much, maybe 5% or 10%," said senior author Dr. Miqin Zhang, professor of materials science and engineering at the University of Washington. "This was quite a surprise to us."

Related Links:
University of Washington


Gold Member
Troponin T QC
Troponin T Quality Control
Automated Blood Typing System
IH-500 NEXT
New
Adenovirus Detection Kit
REALQUALITY RQ-ADENO
New
Thyroid ELISA Kit
AESKULISA a-TPO

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries